Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 1
2013 3
2014 3
2015 5
2016 9
2017 7
2018 5
2019 5
2020 4
2021 6
2022 2
2023 2
2024 4
2025 7
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries.
Bolla E, Semb AG, Kerola AM, Ikdahl E, Petri M, Pons-Estel GJ, Karpouzas GA, Sfikakis PP, Quintana R, Misra DP, Borba EF, Garcia-de la Torre I, Popkova TV, Artim-Esen B, Troldborg A, Fragoso-Loyo H, Ajeganova S, Yazici A, Aroca-Martinez G, Direskeneli H, Ugarte-Gil MF, Mosca M, Goyal M, Svenungsson E, Macieira C, Hoi A, Lerang K, Costedoat-Chalumeau N, Tincani A, Mirrakhimov E, Acosta Colman I, Danza A, Massardo L, Blagojevic J, Yılmaz N, Tegzová D, Yavuz S, Korkmaz C, Hachulla E, Moreno Alvarez MJ, Muñoz-Louis R, Pantazis N, Tektonidou MG; SURF-SLE and APS collaborators. Bolla E, et al. Among authors: ajeganova s. Lancet Rheumatol. 2024 Jul;6(7):e447-e459. doi: 10.1016/S2665-9913(24)00090-0. Epub 2024 Jun 12. Lancet Rheumatol. 2024. PMID: 38878780
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries.
Bolla E, Semb AG, Petri M, Sfikakis PP, Artim-Esen B, Hernandez-Molina G, Hachulla E, Direskeneli H, Karpouzas GA, Zucchi D, Goyal M, Costedoat-Chalumeau N, Tincani A, Yazici A, Lerang K, Troldborg A, Ajeganova S, Popkova TV, Svenungsson E, Pantazis N, Tektonidou MG; SURF-SLE and APS collaborators. Bolla E, et al. Among authors: ajeganova s. Lancet Rheumatol. 2026 Mar;8(3):e192-e203. doi: 10.1016/S2665-9913(25)00257-7. Epub 2025 Nov 19. Lancet Rheumatol. 2026. PMID: 41274305
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial.
Bertrand D, Joly J, Neerinckx B, Durez P, Lenaerts J, Joos R, Thevissen K, Zwaenepoel T, Vanhoof J, Di Romana S, Taelman V, Van Essche E, Corluy L, Ribbens C, Vanden Berghe M, Devinck M, Ajeganova S, Durnez A, Boutsen Y, Margaux J, Peene I, Van Offel J, Doumen M, Pazmino S, De Meyst E, Kulyk M, Creten N, Westhovens R, Verschueren P; CareRA2020 Study group. Bertrand D, et al. Among authors: ajeganova s. RMD Open. 2024 Aug 7;10(3):e004535. doi: 10.1136/rmdopen-2024-004535. RMD Open. 2024. PMID: 39117445 Free PMC article. Clinical Trial.
Inflammation rather than anticitrullinated protein antibodies is associated with cardiovascular mortality in RA: insights from rheumatoid arthritis and coronary artery disease cohorts.
Derksen VFAM, Lindschou J, Winkel P, Delgado GE, de Moel EC, Huizinga TWJ, März W, Jakobsen JC, van der Helm-Van Mil AHM, Toes REM, Ajeganova S, Gluud C, Leipe J, van der Woude D; CLARICOR Trial Group and the LURIC Study Group. Derksen VFAM, et al. Among authors: ajeganova s. Ann Rheum Dis. 2026 Mar;85(3):425-434. doi: 10.1016/j.ard.2025.11.023. Epub 2025 Dec 25. Ann Rheum Dis. 2026. PMID: 41453823 Free article.
Dr. Ajeganova and Dr. Hafström reply.
Ajeganova S, Hafström I. Ajeganova S, et al. J Rheumatol. 2013 Mar;40(3):337. doi: 10.3899/jrheum.121445. J Rheumatol. 2013. PMID: 23577349 No abstract available.
57 results